$79.11
0.55% today
NYSE, Feb 28, 05:17 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Stock price

$78.67
-13.31 14.47% 1M
+6.94 9.68% 6M
-4.04 4.88% YTD
+22.24 39.41% 1Y
+8.35 11.87% 3Y
+31.39 66.39% 5Y
+54.39 224.01% 10Y
NYSE, Closing price Thu, Feb 27 2025
-1.34 1.67%
ISIN
US3795772082
Symbol
GMED
Sector

Key metrics

Market capitalization $10.71b
Enterprise Value $10.36b
P/E (TTM) P/E ratio 105.68
EV/FCF (TTM) EV/FCF 25.57
EV/Sales (TTM) EV/Sales 4.11
P/S ratio (TTM) P/S ratio 4.25
P/B ratio (TTM) P/B ratio 2.59
Revenue growth (TTM) Revenue growth 60.62%
Revenue (TTM) Revenue $2.52b
EBIT (operating result TTM) EBIT $244.91m
Free Cash Flow (TTM) Free Cash Flow $405.21m
Cash position $890.06m
EPS (TTM) EPS $0.74
P/E forward 25.99
P/S forward 4.00
EV/Sales forward 3.86
Short interest 2.15%
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Globus Medical, Inc. Class A forecast:

11x Buy
65%
5x Hold
29%
1x Sell
6%

Analyst Opinions

17 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
65%
Hold
29%
Sell
6%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,519 2,519
61% 61%
100%
- Direct Costs 1,155 1,155
93% 93%
46%
1,365 1,365
41% 41%
54%
- Selling and Administrative Expenses 727 727
47% 47%
29%
- Research and Development Expense 139 139
12% 12%
5%
499 499
43% 43%
20%
- Depreciation and Amortization 254 254
76% 76%
10%
EBIT (Operating Income) EBIT 245 245
20% 20%
10%
Net Profit 103 103
16% 16%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Neutral
Seeking Alpha
8 days ago
Globus Medical, Inc. (NYSE:GMED ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Vik Chopra - Wells Fargo Matt Miksic - Barclays David Saxon - Needham & Company Jason Wittes - ROTH Shagun Singh - RBC Caitlin Cronin - Canac...
Positive
The Motley Fool
8 days ago
Medical technologies specialist Globus Medical (GMED 0.04%) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) of $0.84, exceeding the consensus forecast of $0.75, along with revenue that reached $657.3 million, topping expectations by $12.3 million.
Neutral
GlobeNewsWire
8 days ago
AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2024.
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,300
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today